Translating molecular advances in Down syndrome and Fragile X syndrome into therapies
Ongoing treatments for genetic developmental disorders of the central nervous system are mostly symptomatic and do not correct the genetic cause. Recent identification of common mechanisms between diseases has suggested that new therapeutic targets could be applied across intellectual disabilities w...
Главные авторы: | Faundez, V, De Toma, I, Bardoni, B, Bartesaghi, R, Nizetic, D, de la Torre, R, Kadosh, R, Herault, Y, Dierssen, M, Potier, M-C |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
Elsevier
2018
|
Схожие документы
-
Modeling Fragile X Syndrome in Drosophila
по: Małgorzata Drozd, и др.
Опубликовано: (2018-04-01) -
Fragile X Syndrome as an interneuronopathy: a lesson for future studies and treatments
по: Alessandra Tempio, и др.
Опубликовано: (2023-04-01) -
Fragile X Mental Retardation Protein: To Be or Not to Be a Translational Enhancer
по: Thomas Maurin, и др.
Опубликовано: (2018-12-01) -
A Male with Cooccurrence of Down Syndrome and Fragile X Syndrome
по: Tovi Anderson, и др.
Опубликовано: (2013-01-01) -
The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?
по: Sara Castagnola, и др.
Опубликовано: (2017-11-01)